Sildenafil Tablet, Film Coated
Product Images NDC 68071-2213

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 68071-2213). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2213 9)

This seems to be a description of a medicine called "Sildenafil 20mg", which comes in a bottle of 90 tablets. The lot number is "000000". It is manufactured by a company called "NuCare Pharmaceuticals, Inc." and the NDC code is "68071-2213-09". The expiration date is not available. The label should be consulted for a full list of ingredients. The product should be kept out of reach of children and stored at a controlled temperature between 68-77°F.*

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

This text appears to be a table of recommendations for interacting drugs with sildenafil, with information about drug fold change, recommended dose adjustment, and accumulation ratio. The table includes drugs such as atorvastatin, azithromycin, bosentan, cimetidine, erythromycin, Maalox, oral contraceptives, ritonavir, and saquinavir. The text also includes a graph with a vertical solid line at x=1, showing the change relative to sildenafil alone.*

FDA Label Image

Figure3 (Figure3)

This text is providing information about the interactions of different drugs with Acenocoumarol. It mentions drugs such as Aspirin, Atorvastatin, Bosentan, and others, and how they do not require any dose adjustment, except for Doxazosint and the combination of Doxazosint with Sildenafi, which is not recommended. There is also a mention of Fold Change and 90% CI. Overall, the text is a drug interaction reference guide specifically related to Acenocoumarol.*

FDA Label Image

Figure4 (Figure4)

FDA Label Image

Figure5 (Figure5)

FDA Label Image

Figure6 (Figure6)

FDA Label Image

Figure7 (Figure7)

FDA Label Image

Structure (Structure)

FDA Label Image

Camber1 (Camber1)

FDA Label Image

Camber2 (Camber2)

FDA Label Image

Image1 (Image1)

This text appears to be a chart or graph related to a clinical study evaluating the effects of different doses of a drug called Sildenafil on the distance traveled by patients. The chart shows the mean change from baseline in meters, with data points recorded at different time points up to week 12 of the study. The study involves three groups of patients receiving different doses of Sildenafil, and potentially a placebo control group (not mentioned) because there is no information about the baseline measure. The text mentions the standard error in each group.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.